Moderna stock jumps 12% after $1.9 billion 2025 sales view — what investors watch next

Moderna stock jumps 12% after $1.9 billion 2025 sales view — what investors watch next

Moderna shares jumped 11.7% to $37.81 after the company raised its 2025 sales outlook to about $1.9 billion and cut its operating expense forecast by $200 million. The company reiterated its 2026 growth target and said it does not expect flu or COVID-flu shots to be approved for the 2026 season. Investors await Feb. 13 results and early-2026 cancer vaccine data with Merck.
13 January 2026
Bank of America stock slips as Trump credit-card cap clouds BAC earnings

Bank of America stock slips as Trump credit-card cap clouds BAC earnings

Bank of America shares fell 0.9% to $54.72 Tuesday after President Trump proposed a 10% cap on credit-card interest rates. The move follows a 1.6% drop Monday and comes as U.S. inflation data met expectations, leaving the Fed’s rate outlook unchanged. Bank trade groups warned the cap could force lenders to close or restrict most credit-card accounts for borrowers with scores under 740. Investors await Bank of America’s quarterly results.
IREN Limited stock nudges higher after H.C. Wainwright upgrade as bitcoin firms

IREN Limited stock nudges higher after H.C. Wainwright upgrade as bitcoin firms

IREN Limited shares rose 1% to $50.82 midday Tuesday after H.C. Wainwright upgraded the stock to “buy” with an $80 target. The move followed a $9.7 billion AI cloud deal with Microsoft, though Reuters reported the contract could be canceled if deadlines are missed. Bitcoin climbed 1.5% to $93,434, boosting mining stocks. IREN’s next earnings report is expected Feb. 11, according to MarketBeat.
13 January 2026
Eli Lilly stock (LLY) edges up as FDA clears GLP-1 label cloud; $150 pill launch looms

Eli Lilly stock (LLY) edges up as FDA clears GLP-1 label cloud; $150 pill launch looms

Eli Lilly shares rose 0.2% after the FDA asked drugmakers to remove suicide-related warnings from GLP-1 weight-loss drugs. Lilly’s R&D chief said the company plans a rapid global launch of its oral obesity drug orforglipron, priced at $150 a month. Investors are watching for increased pill competition and the FDA’s upcoming decision.
TTM Technologies stock surges nearly 20% as TTMI draws fresh attention at Needham Growth Conference

TTM Technologies stock surges nearly 20% as TTMI draws fresh attention at Needham Growth Conference

TTM Technologies shares jumped 19% to $92.84 Tuesday morning, leading electronics stocks as traders watched for updates from the Needham Growth Conference in New York. The company’s latest quarter showed net sales up 22% year-over-year to $752.7 million. Wall Street price targets lag behind the current rally. Investors await results from conference meetings and the next earnings report, likely in early February.
13 January 2026
AppLovin stock rises as Wall Street resets targets — what traders are watching next

AppLovin stock rises as Wall Street resets targets — what traders are watching next

AppLovin shares rose 0.5% to $662.24 by 11:12 a.m. ET Tuesday after new broker price targets, rebounding from early swings between $643.00 and $666.57. Morgan Stanley raised its target to $800, while Goldman Sachs trimmed its to $710. The company will report Q4 and full-year 2025 results on Feb. 11. AppLovin remains under SEC investigation over data-collection practices.
13 January 2026
Netflix stock barely moves as Paramount lawsuit intensifies fight over Warner deal

Netflix stock barely moves as Paramount lawsuit intensifies fight over Warner deal

Paramount Skydance sued Warner Bros Discovery and launched a $30-per-share tender offer to block Warner’s $82.7 billion deal with Netflix, which values Warner assets at $27.75 per share. Netflix shares were flat at $89.44 Tuesday, while Warner fell 0.3% and Paramount Skydance slipped 0.5%. Warner’s board called the Paramount bid inferior and warned of a $2.8 billion termination fee if the Netflix deal collapses.
13 January 2026
Intel stock pops after KeyBanc upgrade, $60 target as AI server demand tightens

Intel stock pops after KeyBanc upgrade, $60 target as AI server demand tightens

Intel shares jumped 6.4% to $46.88 Tuesday after KeyBanc upgraded the stock to “overweight” and raised its price target to $60, citing strong server demand and progress in manufacturing. AMD rose 5.7%, while Nvidia slipped 0.2%. Susquehanna raised its Intel target to $40 but warned of PC and data center headwinds. Intel’s new 18A chips, launched at CES, will appear in over 200 PC models this month.
SMCI stock slides after Goldman starts Super Micro at Sell and flags margin downside

SMCI stock slides after Goldman starts Super Micro at Sell and flags margin downside

Goldman Sachs assumed coverage of Super Micro Computer with a Sell rating and a $26 price target, citing shrinking margins and cash pressures amid rising AI-server competition. SMCI shares fell about 6% to $28.31 in late morning trade. Gross margins have contracted for nine quarters, and free cash flow was negative $950 million in Q1 fiscal 2026. Inventory rose to $5.7 billion, with the cash conversion cycle lengthening to 123 days.
13 January 2026
JPMorgan Chase stock falls after Apple Card reserve hits profit as rate-cap risk hangs over banks

JPMorgan Chase stock falls after Apple Card reserve hits profit as rate-cap risk hangs over banks

JPMorgan Chase shares fell 2.5% to $316.32 after reporting fourth-quarter net income of $13.0 billion, or $4.63 a share, including a $2.2 billion reserve for its Apple credit card purchase. Adjusted profit beat forecasts at $5.23 per share, while revenue rose 7% to $45.8 billion. Markets revenue jumped 17% on strong equity trading. The bank warned a proposed 10% cap on credit card rates could force major changes.
13 January 2026
Joby Aviation stock slides in New York trade — what’s moving JOBY after CPI

Joby Aviation stock slides in New York trade — what’s moving JOBY after CPI

Joby Aviation shares fell 6.7% to $14.37 by 10:49 a.m. EST, erasing earlier gains after U.S. inflation data kept annual rates steady. Archer Aviation and Eve Holding also declined, while the S&P 500 and Nasdaq-100 edged lower. Joby recently agreed to buy a property in Ohio for $61.5 million and received its first flight simulator for FAA pilot training. Investors remain focused on certification and facility deadlines.
Intel stock (INTC) jumps on KeyBanc upgrade as AI server-chip pricing comes into view

Intel stock (INTC) jumps on KeyBanc upgrade as AI server-chip pricing comes into view

Intel shares jumped over 6% Tuesday after KeyBanc upgraded the stock, citing strong demand for 2026 server CPUs and possible price hikes of up to 15%. Analyst John Vinh said Intel is nearly sold out of server chips for the year. AMD rose 4.8% on the news, while Nvidia slipped 0.7%. Intel will report earnings Jan. 22.
MARA stock steadies as Bitdeer closes in on mining lead; Washington crypto bill in focus

MARA stock steadies as Bitdeer closes in on mining lead; Washington crypto bill in focus

MARA Holdings shares rose 0.1% to $10.66 Tuesday as bitcoin prices climbed and miners reported tight margins. Bitdeer mined 636 bitcoin in December, closing the production gap with MARA, which mined 675. U.S. senators unveiled draft crypto regulation, while traders await Fed policy signals later this month. Riot Platforms, CleanSpark, and Bitdeer shares also posted modest gains.
Netflix stock stuck near $90 as Paramount sues over Warner deal and analysts reset targets

Netflix stock stuck near $90 as Paramount sues over Warner deal and analysts reset targets

Netflix shares edged up 0.05% to $89.45 Tuesday after Paramount Skydance sued Warner Bros Discovery in Delaware, seeking more disclosure on Warner’s planned deal with Netflix. Paramount also plans a proxy fight at Warner’s 2026 annual meeting. Netflix will report fourth-quarter earnings Jan. 20, with investors watching for updates on the Warner deal and content spending.
Pfizer stock slips as CEO says obesity cash-pay market is “almost like Viagra”

Pfizer stock slips as CEO says obesity cash-pay market is “almost like Viagra”

Pfizer shares fell 0.7% to $25.10 Tuesday after CEO Albert Bourla told the J.P. Morgan Healthcare Conference the cash-pay obesity market is larger than expected. Pfizer plans 10 phase 3 trials for its Metsera drugs by end-2026 but does not expect revenue growth until 2029. Investors await Feb. 3 results for updates on the obesity pipeline and 2026 strategy. Rival Novo Nordisk launched a daily oral Wegovy in the U.S. this month.

Stock Market Today

TSMC stock price jumps 5% as AI capex bets return — what to watch before Taiwan opens

TSMC stock price jumps 5% as AI capex bets return — what to watch before Taiwan opens

8 February 2026
Taipei, Feb 8, 2026, 07:54 (GMT+8) — Market closed Taiwan Semiconductor Manufacturing Co’s U.S.-listed shares jumped 5.5% on Friday, ending at $348.85 as the chip sector snapped back late in the week. (MarketWatch) The bounce matters now because the “AI trade” has been whipsawed by doubts over whether heavy spending will translate into profits, and chip stocks have become the quickest read on that mood. On Friday, the PHLX semiconductor index — a gauge of major U.S. chip shares — closed up 5.7% as Nvidia, AMD and Broadcom led gains. “There’s enough evidence that there’s real demand for AI products
Deutsche Telekom stock slips despite fresh buyback — what matters before earnings

Deutsche Telekom stock slips despite fresh buyback — what matters before earnings

8 February 2026
Deutsche Telekom shares fell 1.1% to 30.26 euros Friday, despite the company repurchasing 250,873 shares for about 7.63 million euros on Xetra. The drop came as European stocks rose and T-Mobile US shares slipped 2.2%. Deutsche Telekom’s 2025 results are due Feb. 26. The company has completed its 2025 buyback and launched a new 2 billion euro programme for 2026.
Airbus stock price ends higher near 191 euros as January deliveries slow, earnings loom

Airbus stock price ends higher near 191 euros as January deliveries slow, earnings loom

8 February 2026
Airbus shares rose 0.94% to 191.30 euros Friday as the company reported 19 aircraft deliveries in January, down from 25 a year earlier. Supply chain bottlenecks remain an issue, with executives at the Singapore Airshow calling delays “unacceptable.” Jefferies kept a Neutral rating and a 215-euro price target. Airbus will report full-year 2025 results on Feb. 19.
Banco Santander stock heads into Monday after Friday bounce as buyback and Webster deal loom

Banco Santander stock heads into Monday after Friday bounce as buyback and Webster deal loom

8 February 2026
Banco Santander shares closed up 1.85% at €10.66 in Madrid Friday after launching a €5.03 billion buyback and agreeing to acquire U.S. lender Webster Financial for $12.2 billion. Santander said its board will review the 2025 cash dividend proposal on Feb. 24. The bank also raised its UK motor finance redress provision to £461 million amid regulatory uncertainty.
Go toTop